• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄相关的黄斑变性的全球负担存在地域差异。

Regional differences in the global burden of age-related macular degeneration.

机构信息

Department of Ophthalmology, The Second Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang, Hangzhou, China.

出版信息

BMC Public Health. 2020 Mar 30;20(1):410. doi: 10.1186/s12889-020-8445-y.

DOI:10.1186/s12889-020-8445-y
PMID:32228540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7106756/
Abstract

BACKGROUND

Age-related Macular Degeneration (AMD) is the leading cause of blindness. This study aims to analyze regional differences on the global burden of AMD and help direct related policy making.

METHODS

Disability-adjusted life years (DALY) data were collected from the Global Burden of Disease Study (GBD) 2017 to estimate the AMD burden. Mean education years, human development index (HDI) and Public Health Expenditure were extracted from the Human Development Report 2018, and latitude data were obtained from the Google Earth. These four factors were analyzed to see their importance in regional differences of AMD burden, using Kruskal-Wallis test, Dunn's multiple comparisons test as well as regression analysis.

RESULTS

Global age-standardized DALY rates have decreased since 2011. Based on the WHO region system, age-standardized DALY rates in African and Eastern Mediterranean region were significantly lower than those of other four regions. Linear regression analysis indicated that age-standardized DALY rates were inversely related to HDI and mean education years.

CONCLUSIONS

The age-standardized AMD burden had a decreasing tendency recently. Lower socioeconomic status and fewer education years were associated with higher AMD burden. The finding of this study may highlight the importance of national development and education on relieving AMD burden.

摘要

背景

年龄相关性黄斑变性(AMD)是导致失明的主要原因。本研究旨在分析 AMD 全球负担的地区差异,为相关政策制定提供指导。

方法

使用 2017 年全球疾病负担研究(GBD)收集的残疾调整生命年(DALY)数据来评估 AMD 负担。从 2018 年人类发展报告中提取平均受教育年限、人类发展指数(HDI)和公共卫生支出,从谷歌地球获取纬度数据。采用 Kruskal-Wallis 检验、Dunn's 多重比较检验和回归分析,分析这些因素对 AMD 负担地区差异的重要性。

结果

自 2011 年以来,全球年龄标准化 DALY 率呈下降趋势。根据世界卫生组织(WHO)区域系统,非洲和东地中海地区的年龄标准化 DALY 率明显低于其他四个地区。线性回归分析表明,年龄标准化 DALY 率与 HDI 和平均受教育年限呈负相关。

结论

最近,年龄标准化 AMD 负担呈下降趋势。较低的社会经济地位和较少的受教育年限与较高的 AMD 负担相关。本研究的结果可能强调了国家发展和教育对减轻 AMD 负担的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/9efcd88051cc/12889_2020_8445_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/b1b5395fc02a/12889_2020_8445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/5a81a43f357e/12889_2020_8445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/efd25ae54ca9/12889_2020_8445_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/7c6cffdd9446/12889_2020_8445_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/21ce3f987d38/12889_2020_8445_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/bfe2c09db52b/12889_2020_8445_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/5f99dba1b045/12889_2020_8445_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/9efcd88051cc/12889_2020_8445_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/b1b5395fc02a/12889_2020_8445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/5a81a43f357e/12889_2020_8445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/efd25ae54ca9/12889_2020_8445_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/7c6cffdd9446/12889_2020_8445_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/21ce3f987d38/12889_2020_8445_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/bfe2c09db52b/12889_2020_8445_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/5f99dba1b045/12889_2020_8445_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c82/7106756/9efcd88051cc/12889_2020_8445_Fig8_HTML.jpg

相似文献

1
Regional differences in the global burden of age-related macular degeneration.与年龄相关的黄斑变性的全球负担存在地域差异。
BMC Public Health. 2020 Mar 30;20(1):410. doi: 10.1186/s12889-020-8445-y.
2
Disparities in the Global Burden of Age-Related Macular Degeneration: An Analysis of Trends from 1990 to 2015.全球年龄相关性黄斑变性负担的差异:1990 年至 2015 年趋势分析。
Curr Eye Res. 2019 Jun;44(6):657-663. doi: 10.1080/02713683.2019.1576907. Epub 2019 Feb 18.
3
Variations and trends in global disease burden of age-related macular degeneration: 1990-2017.全球与年龄相关性黄斑变性相关疾病负担的变化和趋势:1990-2017 年。
Acta Ophthalmol. 2021 May;99(3):e330-e335. doi: 10.1111/aos.14589. Epub 2020 Aug 24.
4
Global Patterns in Health Burden of Uncorrected Refractive Error.未矫正屈光不正所致健康负担的全球模式
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6271-6277. doi: 10.1167/iovs.16-20242.
5
Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016.全球青光眼负担的社会经济差异:1990 年至 2016 年趋势分析。
Graefes Arch Clin Exp Ophthalmol. 2020 Mar;258(3):587-594. doi: 10.1007/s00417-019-04484-y. Epub 2019 Dec 9.
6
The pattern and gender disparity in global burden of age-related macular degeneration.年龄相关性黄斑变性全球负担的模式和性别差异。
Eur J Ophthalmol. 2021 May;31(3):1161-1170. doi: 10.1177/1120672120927256. Epub 2020 Jun 4.
7
Association of Sex With the Global Burden of Cataract.性别与白内障全球负担的关联。
JAMA Ophthalmol. 2018 Feb 1;136(2):116-121. doi: 10.1001/jamaophthalmol.2017.5668.
8
Analysis of the epidemiological burden of age-related macular degeneration in China based on the data of global burden of disease.基于全球疾病负担数据的中国年龄相关性黄斑变性的流行病学负担分析。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Jan 28;48(1):106-113. doi: 10.11817/j.issn.1672-7347.2023.220368.
9
Gender Inequality in Global Burden of Uncorrected Refractive Error.全球未矫正屈光不正负担中的性别不平等。
Am J Ophthalmol. 2019 Feb;198:1-7. doi: 10.1016/j.ajo.2018.09.020. Epub 2018 Sep 27.
10
Disease burden of age-related macular degeneration in China from 1990 to 2019: findings from the global burden of disease study.2019 年中国与年龄相关性黄斑变性相关的疾病负担:来自全球疾病负担研究的结果。
J Glob Health. 2021 Oct 30;11:08009. doi: 10.7189/jogh.11.08009. eCollection 2021.

引用本文的文献

1
Combined exposure to three heavy metals and the risk of age-related macular degeneration in the Korean population.韩国人群中三种重金属的联合暴露与年龄相关性黄斑变性的风险
Sci Rep. 2025 Jul 25;15(1):27016. doi: 10.1038/s41598-025-12671-7.
2
Global burden of smoking-associated age-related macular degeneration: Spatiotemporal trends from 1990 to 2021 and projections to 2040.吸烟相关年龄相关性黄斑变性的全球负担:1990年至2021年的时空趋势及到2040年的预测
Tob Induc Dis. 2025 Jul 11;23. doi: 10.18332/tid/205665. eCollection 2025.
3
Global trends and disparities in burden of blindness and vision loss caused by non-communicable diseases from 1990 to 2021, and forecasts to 2045: a systematic analysis for the global burden of disease study 2021.

本文引用的文献

1
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
2
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
3
1990年至2021年非传染性疾病所致失明和视力丧失负担的全球趋势与差异,以及到2045年的预测:全球疾病负担研究2021的系统分析
Front Med (Lausanne). 2025 Jun 19;12:1561568. doi: 10.3389/fmed.2025.1561568. eCollection 2025.
4
The burden of age-related macular degeneration and its socioeconomic associates in the Eastern Mediterranean Region from 1990 to 2021.1990年至2021年东地中海区域年龄相关性黄斑变性及其社会经济关联因素的负担
Sci Rep. 2025 Jul 1;15(1):21950. doi: 10.1038/s41598-025-04196-w.
5
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
6
Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021.改善年龄相关性黄斑变性负担的潜力:2021年全球疾病负担研究结果
Eye (Lond). 2025 Apr 23. doi: 10.1038/s41433-025-03786-2.
7
Burdens and trends of age-related macular degeneration at global, regional, and national levels,1990-2021: findings from the 2021 global burden of disease study.1990 - 2021年全球、区域和国家层面年龄相关性黄斑变性的负担与趋势:2021年全球疾病负担研究的结果
Eye (Lond). 2025 Jun;39(8):1517-1525. doi: 10.1038/s41433-025-03686-5. Epub 2025 Feb 17.
8
Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 2050.1990年至2021年因年龄相关性黄斑变性导致的低视力和失明的全球负担及2050年预测
BMC Public Health. 2024 Dec 18;24(1):3510. doi: 10.1186/s12889-024-21047-x.
9
Global, regional, and national burden of age-related macular degeneration, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 Study.全球、区域和国家与年龄相关的黄斑变性负担,1990-2019 年:基于 2019 年全球疾病负担研究的年龄-时期-队列分析。
Front Public Health. 2024 Oct 22;12:1486168. doi: 10.3389/fpubh.2024.1486168. eCollection 2024.
10
Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics.年龄相关性黄斑变性(AMD):发病机制、药物靶点方法及纳米治疗学的最新进展。
Medicina (Kaunas). 2024 Oct 8;60(10):1647. doi: 10.3390/medicina60101647.
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.年龄相关性黄斑变性(AMD)的流行病学:与心血管疾病表型和脂质因素的关联
Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. eCollection 2016.
4
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
5
Geo-Epidemiology of Age-Related Macular Degeneration: New Clues Into the Pathogenesis.年龄相关性黄斑变性的地理流行病学:发病机制的新线索
Am J Ophthalmol. 2016 Jan;161:78-93.e1-2. doi: 10.1016/j.ajo.2015.09.031. Epub 2015 Oct 24.
6
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测:系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
7
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD.玻璃体内注射雷珠单抗、贝伐单抗或阿柏西普治疗新生血管性年龄相关性黄斑变性患者后的全身药代动力学。
Br J Ophthalmol. 2014 Dec;98(12):1636-41. doi: 10.1136/bjophthalmol-2014-305252. Epub 2014 Jul 7.
8
Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays.新加坡华人、印度人和马来人中与年龄相关的黄斑变性的患病率、种族差异和危险因素。
Ophthalmology. 2014 Aug;121(8):1598-603. doi: 10.1016/j.ophtha.2014.02.004. Epub 2014 Mar 22.
9
Prevalence and characteristics of age-related macular degeneration in the Japanese population: the Nagahama study.日本人群中年龄相关性黄斑变性的患病率及特征:长滨研究。
Am J Ophthalmol. 2013 Nov;156(5):1002-1009.e2. doi: 10.1016/j.ajo.2013.06.007. Epub 2013 Aug 12.
10
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial.雷珠单抗与贝伐单抗治疗新生血管性年龄相关性黄斑变性的比较:来自 GEFAL 非劣效性随机试验的结果。
Ophthalmology. 2013 Nov;120(11):2300-9. doi: 10.1016/j.ophtha.2013.06.020. Epub 2013 Aug 2.